3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
19
Prostatic Neoplasms
9
Polycystic Ovary Syndrome
7
Vitamin D Deficiency
6
Osteoporosis
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
4
Colonic Neoplasms
4
Obesity
3
Inflammation
3
Colorectal Neoplasms
3
Bone Diseases, Metabolic
3
Neoplasm Metastasis
2
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Lung Neoplasms
2
Leukemia
2
Gastrointestinal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Cancers
1
Interventions
Aromatase Inhibitors
2
Vitamin D
1
Tobacco Products
1
Propofol
1
Neuroleptanalgesia
1
Midazolam
1
Letrozole
1
Hormone Replacement Therapy
1
Heart Disease Risk Factors
1
Exercise
1
Etomidate
1
Ethanol
1
Cholecalciferol
1
Cari-D-Tect
1
Aspirin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fractures, Bone
×
Vitamin D
×
Clear all
NCT01646437
2021-09-16
TIPS-3
Population Health Research Institute
Phase 3
Completed
7,793 enrolled